NCT01877668 Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study Status COMPLETED Phase PHASE3
NCT01870284 Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) Status WITHDRAWN Phase PHASE3
NCT01812954 Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis Status COMPLETED Phase N/A
NCT01808118 Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis Status COMPLETED Phase PHASE3
NCT01793519 Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01764997 An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate Status TERMINATED Phase PHASE3
NCT01736189 Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice Status COMPLETED Phase N/A
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis Status COMPLETED Phase PHASE4
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC) Status TERMINATED Phase PHASE2
NCT01695239 A Study of Ixekizumab in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01646073 Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01644396 An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation Status COMPLETED Phase PHASE4
NCT01635764 Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Status UNKNOWN Phase PHASE3